Skip to content
healthcare.dev

EVRYSDI

NDC 50242-175, Risdiplam, powder, for solution, from Genentech, Inc..

Product NDC
50242-175
Status
Listed
Labeler
Genentech, Inc.
Dosage form
POWDER, FOR SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213535
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-175 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RISDIPLAM.75 mg/mL

Pharmacologic classes

Increased Protein Synthesis [PE]; Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]; Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]; Survival of Motor Neuron 2 Splicing Modifier [EPC]; Survival of Motor Neuron 2 Splicing Modifiers [MoA]

Package NDCNDC-11Package
50242-175-07502420175071 BOTTLE, GLASS in 1 CARTON (50242-175-07) / 80 mL in 1 BOTTLE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/eceb9a99-7191-4be5-87c3-0102707cf98e

Use it

Look up 50242-175 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-175 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-175. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.